Cns Pharmaceuticals Stock Price History
| CNSP Stock | USD 0.11 0.01 8.33% |
Below is the normalized historical share price chart for Cns Pharmaceuticals extending back to November 08, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cns Pharmaceuticals stands at 0.11, as last reported on the 4th of November, with the highest price reaching 0.11 and the lowest price hitting 0.10 during the day.
If you're considering investing in Cns Stock, it is important to understand the factors that can impact its price. Cns Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0491, which signifies that the company had a -0.0491% return per unit of risk over the last 3 months. Cns Pharmaceuticals exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cns Pharmaceuticals' Risk Adjusted Performance of (0.09), mean deviation of 5.97, and Standard Deviation of 8.47 to double-check the risk estimate we provide.
At this time, Cns Pharmaceuticals' Common Stock is relatively stable compared to the past year. As of 11/04/2024, Capital Stock is likely to grow to about 11.8 K, while Common Stock Shares Outstanding is likely to drop slightly above 71.6 K. . As of 11/04/2024, Price Earnings Ratio is likely to drop to -0.27. In addition to that, Price Book Value Ratio is likely to grow to -1.02. Cns Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of November 2019 | 200 Day MA 7.2988 | 50 Day MA 0.1398 | Beta 1.046 |
Cns |
Sharpe Ratio = -0.0491
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CNSP |
Estimated Market Risk
| 7.77 actual daily | 69 69% of assets are less volatile |
Expected Return
| -0.38 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Cns Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cns Pharmaceuticals by adding Cns Pharmaceuticals to a well-diversified portfolio.
Price Book 4.571 | Book Value (2.98) | Enterprise Value 3.2 M | Enterprise Value Ebitda 0.4007 | Shares Float 31.4 M |
Cns Pharmaceuticals Stock Price History Chart
There are several ways to analyze Cns Stock price data. The simplest method is using a basic Cns candlestick price chart, which shows Cns Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | August 23, 2024 | 0.2 |
| Lowest Price | October 7, 2024 | 0.11 |
Cns Pharmaceuticals November 4, 2024 Stock Price Synopsis
Various analyses of Cns Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cns Stock. It can be used to describe the percentage change in the price of Cns Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cns Stock.| Cns Pharmaceuticals Price Rate Of Daily Change | 0.92 | |
| Cns Pharmaceuticals Price Daily Balance Of Power | (1.00) | |
| Cns Pharmaceuticals Accumulation Distribution | 425,499 |
Cns Pharmaceuticals November 4, 2024 Stock Price Analysis
Cns Stock Price History Data
The price series of Cns Pharmaceuticals for the period between Tue, Aug 6, 2024 and Mon, Nov 4, 2024 has a statistical range of 0.18 with a coefficient of variation of 20.37. The prices are distributed with arithmetic mean of 0.15. The median price for the last 90 days is 0.14. The company had 1:50 stock split on 5th of June 2024.| Open | High | Low | Close | Volume | ||
| 11/04/2024 | 0.10 | 0.11 | 0.10 | 0.11 | 4,680,493 | |
11/04/2024 | 0.12 | 0.13 | 0.11 | 0.11 | ||
| 11/01/2024 | 0.12 | 0.13 | 0.11 | 0.11 | 13,359,690 | |
| 10/31/2024 | 0.12 | 0.12 | 0.11 | 0.11 | 5,732,669 | |
| 10/30/2024 | 0.13 | 0.14 | 0.12 | 0.12 | 8,209,229 | |
| 10/29/2024 | 0.14 | 0.16 | 0.14 | 0.14 | 10,778,420 | |
| 10/28/2024 | 0.13 | 0.15 | 0.13 | 0.14 | 13,877,830 | |
| 10/25/2024 | 0.14 | 0.15 | 0.12 | 0.13 | 21,441,180 | |
| 10/24/2024 | 0.18 | 0.19 | 0.14 | 0.15 | 71,973,680 | |
| 10/23/2024 | 0.32 | 0.37 | 0.14 | 0.14 | 567,767,500 | |
| 10/22/2024 | 0.15 | 0.16 | 0.14 | 0.16 | 20,272,461 | |
| 10/21/2024 | 0.12 | 0.15 | 0.12 | 0.15 | 5,972,683 | |
| 10/18/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 444,073 | |
| 10/17/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 663,484 | |
| 10/16/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 557,788 | |
| 10/15/2024 | 0.13 | 0.13 | 0.12 | 0.12 | 499,488 | |
| 10/14/2024 | 0.12 | 0.13 | 0.12 | 0.12 | 948,435 | |
| 10/11/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 798,667 | |
| 10/10/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 1,182,663 | |
| 10/09/2024 | 0.13 | 0.13 | 0.12 | 0.12 | 1,062,449 | |
| 10/08/2024 | 0.12 | 0.13 | 0.11 | 0.13 | 4,193,898 | |
| 10/07/2024 | 0.13 | 0.13 | 0.11 | 0.11 | 1,413,120 | |
| 10/04/2024 | 0.12 | 0.12 | 0.12 | 0.12 | 703,220 | |
| 10/03/2024 | 0.13 | 0.13 | 0.12 | 0.12 | 946,177 | |
| 10/02/2024 | 0.13 | 0.13 | 0.12 | 0.12 | 1,612,448 | |
| 10/01/2024 | 0.14 | 0.14 | 0.13 | 0.13 | 791,196 | |
| 09/30/2024 | 0.14 | 0.14 | 0.13 | 0.13 | 1,387,518 | |
| 09/27/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 670,562 | |
| 09/26/2024 | 0.15 | 0.15 | 0.13 | 0.14 | 1,006,257 | |
| 09/25/2024 | 0.14 | 0.15 | 0.14 | 0.14 | 454,679 | |
| 09/24/2024 | 0.14 | 0.14 | 0.14 | 0.14 | 557,399 | |
| 09/23/2024 | 0.15 | 0.15 | 0.14 | 0.14 | 1,489,911 | |
| 09/20/2024 | 0.15 | 0.16 | 0.14 | 0.14 | 798,852 | |
| 09/19/2024 | 0.16 | 0.16 | 0.15 | 0.15 | 1,474,255 | |
| 09/18/2024 | 0.16 | 0.16 | 0.16 | 0.16 | 956,710 | |
| 09/17/2024 | 0.15 | 0.16 | 0.15 | 0.15 | 895,191 | |
| 09/16/2024 | 0.15 | 0.16 | 0.14 | 0.15 | 1,053,900 | |
| 09/13/2024 | 0.15 | 0.15 | 0.14 | 0.15 | 1,423,750 | |
| 09/12/2024 | 0.16 | 0.17 | 0.15 | 0.15 | 2,637,139 | |
| 09/11/2024 | 0.15 | 0.16 | 0.14 | 0.16 | 4,963,227 | |
| 09/10/2024 | 0.16 | 0.17 | 0.14 | 0.15 | 5,687,185 | |
| 09/09/2024 | 0.15 | 0.15 | 0.13 | 0.14 | 1,244,347 | |
| 09/06/2024 | 0.15 | 0.16 | 0.14 | 0.14 | 871,203 | |
| 09/05/2024 | 0.15 | 0.16 | 0.15 | 0.15 | 1,226,823 | |
| 09/04/2024 | 0.16 | 0.16 | 0.14 | 0.15 | 909,068 | |
| 09/03/2024 | 0.15 | 0.16 | 0.15 | 0.15 | 838,896 | |
| 08/30/2024 | 0.15 | 0.17 | 0.14 | 0.16 | 1,766,387 | |
| 08/29/2024 | 0.16 | 0.16 | 0.14 | 0.15 | 1,622,047 | |
| 08/28/2024 | 0.16 | 0.17 | 0.15 | 0.15 | 1,877,084 | |
| 08/27/2024 | 0.18 | 0.18 | 0.17 | 0.17 | 2,114,080 | |
| 08/26/2024 | 0.19 | 0.19 | 0.17 | 0.18 | 3,833,130 | |
| 08/23/2024 | 0.18 | 0.20 | 0.17 | 0.20 | 6,061,370 | |
| 08/22/2024 | 0.16 | 0.18 | 0.16 | 0.17 | 3,678,692 | |
| 08/21/2024 | 0.17 | 0.17 | 0.16 | 0.17 | 3,089,121 | |
| 08/20/2024 | 0.15 | 0.19 | 0.15 | 0.17 | 11,286,890 | |
| 08/19/2024 | 0.14 | 0.15 | 0.13 | 0.14 | 4,237,571 | |
| 08/16/2024 | 0.15 | 0.16 | 0.1 | 0.13 | 5,234,027 | |
| 08/15/2024 | 0.13 | 0.14 | 0.13 | 0.14 | 3,616,747 | |
| 08/14/2024 | 0.15 | 0.15 | 0.13 | 0.14 | 4,244,236 | |
| 08/13/2024 | 0.16 | 0.16 | 0.14 | 0.15 | 4,430,689 | |
| 08/12/2024 | 0.18 | 0.18 | 0.16 | 0.16 | 3,529,920 |
About Cns Pharmaceuticals Stock history
Cns Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cns is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cns Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cns Pharmaceuticals stock prices may prove useful in developing a viable investing in Cns Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 75.3 K | 71.6 K | |
| Net Loss | -12.6 M | -12 M |
Cns Pharmaceuticals Stock Technical Analysis
Cns Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Cns Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cns Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Cns Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cns to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.27) | |||
| Total Risk Alpha | (1.74) | |||
| Treynor Ratio | (0.40) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Cns Stock Analysis
When running Cns Pharmaceuticals' price analysis, check to measure Cns Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cns Pharmaceuticals is operating at the current time. Most of Cns Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cns Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cns Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cns Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.